Related Experiment Videos
Functional roles of E2F in cell cycle regulation
1Program for Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Oncogene
|March 13, 1997
Summary
A dominant-negative E2F mutant (E2F97) inhibits cell cycle progression by reducing key proteins like cyclin A and D1. This study reveals E2F
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Research
Background:
- The E2F family of transcription factors is crucial for cell cycle progression, particularly the G1-S phase transition.
- Understanding E2F's regulatory mechanisms is vital for deciphering cell proliferation and developing cancer therapies.
Purpose of the Study:
- To investigate the mechanism by which a dominant-negative E2F1 mutant (E2F97) affects cell cycle progression.
- To examine the impact of E2F97 on the expression of key cell cycle regulatory proteins.
Main Methods:
- Construction of a tetracycline-responsive dominant-negative E2F1 mutant (E2F97).
- Generation of stable transfectants in SaOS-2 and VA-13 cell lines.
- Analysis of cell cycle protein levels and transcriptional activity upon E2F97 induction.
Main Results:
- E2F97 induction significantly inhibited E2F transcriptional activity and reduced the percentage of cells in S-phase.
- Downregulation of dihydrofolate reductase, thymidylate synthase, cyclin A, and cyclin D1 protein levels was observed.
- Regulation of cyclin A by E2F97 occurred at the transcriptional level.
- In VA13 cells, E2F97 induction led to the downregulation of the tumor suppressor protein p53.
Conclusions:
- E2F transcription factors regulate both G1 and S-phase cyclins.
- A potential positive feedback loop may exist between E2F and cyclin D1.
- E2F97 serves as a valuable tool for dissecting cell cycle control mechanisms.